<!DOCTYPE html>
<meta charset="utf-8" />
<meta
    name="viewport"
    content="width=device-width, height=device-height, initial-scale=1, shrink-to-fit=yes" />

<!-- <link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/css/bootstrap.min.css" integrity="sha384-ggOyR0iXCbMQv3Xipma34MD+dH/1fQ784/j6cY/iJTQUOhcWr7x9JvoRxT2MZw1T" crossorigin="anonymous"> -->
<link rel="stylesheet" href="bootstrap.min.css">
<style type="text/css">
 .org-right  { margin-left: auto; margin-right: 0px;  text-align: right; }
 .org-left   { margin-left: 0px;  margin-right: auto; text-align: left; }
 .org-center { margin-left: auto; margin-right: auto; text-align: center; }
 .modal { overflow-y: auto }
</style>
<body>
    <title>pCR-BCa-CEA-tool</title>


    <!-- https://www.w3schools.com/js/js_json.asp -->
    <!-- <script src="https://d3js.org/d3.v5.min.js"></script> -->
    <script type="text/javascript" src="d3.v5.min.js"></script>
    <!-- <script src="https://unpkg.com/d3-simple-slider"></script>
         <script src="https://unpkg.com/d3-simple-slider@1.9.0/dist/d3-simple-slider.min.js"></script> -->
    <script type="text/javascript" src="d3-simple-slider.min.js"></script>
    <script type="text/javascript" src="effects.json"></script>
    <!-- <script src="errorbar.js"></script> -->
    <!-- <script src="https://code.jquery.com/jquery-3.3.1.slim.min.js" integrity="sha384-q8i/X+965DzO0rT7abK41JStQIAqVgRVzpbzo5smXKp4YfRvH+8abtTE1Pi6jizo" crossorigin="anonymous"></script>
         <script src="https://cdnjs.cloudflare.com/ajax/libs/popper.js/1.14.7/umd/popper.min.js" integrity="sha384-UO2eT0CpHqdSJQ6hJty5KVphtPhzWj9WO1clHTMGa3JDZwrnQq4sF86dIHNDz0W1" crossorigin="anonymous"></script>
         <script src="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/js/bootstrap.min.js" integrity="sha384-JjSmVgyd0p3pXB1rRibZUAYoIIy6OrQ6VrjIEaFf/nJGzIxFDsf4x0xIM+B07jRM" crossorigin="anonymous"></script> -->
    <script type="text/javascript" src="jquery-3.3.1.slim.min.js"></script>
    <script type="text/javascript" src="popper.min.js"></script>
    <script type="text/javascript" src="bootstrap.min.js"></script>
    <div class="container">
        <h1>pCR based Cost-Effectiveness Calculator</h1>
        <div id="text"></div>
        <div class="row align-items-center">
            <div id="my_dataviz"></div>
            <div class="row align-items-top">
                <div class="col align-items-left">
                    <!-- Initialize a select buttons -->
                    <h6 class="text-left">Breast cancer subtype</h6>
                    <div class="mt-3 col-md-12">
                        <select id="selectButton" class="btn btn-primary dropdown-toggle"></select>
                    </div>
                    <div class="mt-3 col-md-12">
                        <button type="button" class="btn btn-primary" data-toggle="modal" data-target="#infoModal">
                            About
                        </button>
                    </div>
                </div>
                <div class="col align-items-left">
                    <h6 class="text-center">Difference in pCR rate</h6>
                    <div id="slider-pcr"></div>
                    <h6 class="text-center">Cost of intervention</h6>
                    <div id="slider-cost"></div>
                    <h6 class="text-center">Willingness to pay per life-year</h6>
                    <div id="slider-wtp"> </div>
                </div>
            </div>
        </div>
    </div>
    <div class="modal fade" id="infoModal" role="dialog">
        <div class="modal-dialog modal-lg">
            <div class="modal-content">
                <div class="modal-header">
                    <h4 class="modal-title">Description of cost-effectiveness calculations for neoadjuvant breast cancer treatments based on the rate of pathologic complete response</h4>
                    <button type="button" class="close" data-dismiss="modal">&times;</button>
                </div>
                <div class="modal-body">
                    <h4>Background</h4>
                    <p>
                        Neoadjuvant treatment for breast cancer, allows
                        for measuring the early endpoint, complete
                        pathologic response (pCR). The I-SPY 2 trial (identifier: NCT01042379) uses
                        pCR as primary outcome when screening for emerging
                        agents. This tool allows for early assessment of a
                        treatment's cost-effectiveness based on how much the
                        treatment improves the pCR rate.
                    </p>
                    <h4>Methods</h4>
                    <p>
                        We developed a Markov model for predicting
                        future life-years and costs. The model was based
                        on I-SPY 2 data, complemented by SEER data and
                        accounted for time-varying effects and cancer
                        subtypes. We attained state and subtype specific
                        costs from a systematic review of the
                        literature, see
                        <a data-toggle="modal" href="#costModal" class="button">cost inputs</a>.
                    </p>
                    <h4>Visualisation</h4>
                    <p>
                        The plot shows a cost-effectiveness plane with the
                        differences in costs and life-years. The point
                        illustrates the differences between a treatment arm
                        and the control arm, given a difference in pCR rate,
                        a breast cancer subtype and a cost of the
                        intervention.
                    </p>
                    <h4>Predictions</h4>
                    <p>
                        <h5>ICER</h5>
                        <p>
                            Incremental cost-effectiveness ratio (ICER),
                            summarises the cost-effectiveness of an
                            intervention. The difference in cost is divided
                            through the difference in effect, here expressed as
                            US dollars per life-year. The ICER can be used as a
                            decision rule when allocating health care
                            resources. If a value of the willingness to pay per
                            life-year can be asstablished, this value can be
                            adopted as a threshold. If the ICER is above the
                            willingness to pay per life-year the intervention is
                            too expensive and should not be funded, but if the
                            ICER is below the willingness to pay per life-year
                            the intervention is cost-effective.
                        </p>

                        <h5>Life-years gained</h5>
                        <p>
                            The effectiveness measure, presented as life-years
                            gained, which is defined as the predicted life-years
                            for the treatment arm minus the predicted life-years
                            for the control arm.
                        </p>
                        <h5>Costs</h5>
                        <p>
                            The cost difference is defined as the predicted
                            lifetime healthcare costs for the treatment arm
                            minus the predicted lifetime healthcare costs for
                            the control arm. A negative cost difference implies
                            that an intervention is cost saving.
                        </p>
                        <h5>Credible Intervals (CrI)</h5>
                        <p>
                            To quantify the prediction uncertainty a
                            probabilistic sensitivity analysis was performed and
                            the results were used to provide 95% credible
                            intervals (CrI).
                        </p>
                    </p>
                    <h4>Interactions</h4>
                    <p>
                        <h5>Difference in pCR rate</h5>
                        <p>
                            Difference in pCR rate between the treatment and
                            the control arm, i.e. if 60% of the women in the
                            treatment arm had a pCR and 20% of the women in
                            the control arm had a pCR the difference in pCR rate
                            would be 40%.
                        </p>
                        <h5>Cost of intervention</h5>
                        <p>
                            The costs associated with the intervention in the
                            treatment arm.
                        </p>
                        <h5>Willingness to pay per life-year</h5>
                        <p>
                            A threshold value, here expressed as US dollars per
                            life-year, below which a treament is deemed
                            cost-effective. The threshold value is illustrated
                            as the dark green line and the area below, where an
                            intervention is cost-effective, is shown in light
                            green.
                        </p>
                        <h5>Breast cancer subtype</h5>
                        <p>
                            The predictions are specific to four combinations of
                            molecular subtypes in breast cancer, determined by
                            hormone receptor status (HR) and the status of human
                            epidermal growth factor receptor 2 (HER2).
                        </p>
                    </p>
                </div>
                <div class="modal-footer">
                    <button type="button" class="btn btn-default" data-dismiss="modal">Close</button>
                </div>
            </div>
        </div>
    </div>
    <!-- The Modal -->
    <div class="modal fade" id="costModal">
        <div class="modal-dialog modal-xl">
            <div class="modal-content">

                <!-- Modal Header -->
                <div class="modal-header">
                    <h4 class="modal-title">Literature cost inputs</h4>
                    <button type="button" class="close" data-dismiss="modal">&times;</button>
                </div>

                <!-- Modal body -->
                <div class="modal-body">
                    <table border="2" cellspacing="0" cellpadding="6" rules="groups" frame="hsides">
                        <colgroup>
                            <col  class="org-left" />

                            <col  class="org-right" />

                            <col  class="org-left" />

                            <col  class="org-right" />

                            <col  class="org-right" />

                            <col  class="org-left" />
                        </colgroup>
                        <thead>
                            <tr>
                                <th scope="col" class="org-left">State</th>
                                <th scope="col" class="org-right">Year</th>
                                <th scope="col" class="org-left">Subtypes</th>
                                <th scope="col" class="org-right">Cost</th>
                                <th scope="col" class="org-right">Range</th>
                                <th scope="col" class="org-left">Source</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td class="org-left" rowspan="2">Disease-free</td>
                                <td class="org-right">1</td>
                                <td class="org-left">All Subtypes</td>
                                <td class="org-right">$2,206</td>
                                <td class="org-right">$1,655−2,759</td>
                                <td class="org-left">Alvarado et al. (2013)</td>
                            </tr>

                            <tr>
                                <td class="org-right">2+</td>
                                <td class="org-left">All Subtypes</td>
                                <td class="org-right">$2,206</td>
                                <td class="org-right">$1,655−2,759</td>
                                <td class="org-left">Alvarado et al. (2013)</td>
                            </tr>
                        </tbody>
                        <tbody>
                            <tr>
                                <td class="org-left" rowspan="2">Local/Regional Recurrence</td>
                                <td class="org-right">1</td>
                                <td class="org-left">All Subtypes</td>
                                <td class="org-right">$39,169</td>
                                <td class="org-right">$29,376−48,961</td>
                                <td class="org-left">Lamerato et al. (2006), Stokes et al. (2008)</td>
                            </tr>

                            <tr>
                                <td class="org-right">2+</td>
                                <td class="org-left">All Subtypes</td>
                                <td class="org-right">$5,690</td>
                                <td class="org-right">$0−11,380</td>
                                <td class="org-left">Stokes et al. (2008), Delea et al. (2007), Blumen et al. (2016).</td>
                            </tr>
                        </tbody>
                        <tbody>
                            <tr>
                                <td class="org-left" rowspan="4">Metastatic Recurrence</td>
                                <td class="org-right">1+</td>
                                <td class="org-left">HR+/HER2+</td>
                                <td class="org-right">$126,391</td>
                                <td class="org-right">$94,793−157,989</td>
                                <td class="org-left">Montero et al. (2012)</td>
                            </tr>

                            <tr>
                                <td class="org-right">1+</td>
                                <td class="org-left">HR+/HER2-</td>
                                <td class="org-right">$75,760</td>
                                <td class="org-right">$56,820−94,700</td>
                                <td class="org-left">Montero et al. (2012)</td>
                            </tr>

                            <tr>
                                <td class="org-right">1+</td>
                                <td class="org-left">HR-/HER2+</td>
                                <td class="org-right">$144,049</td>
                                <td class="org-right">$108,037−180,061</td>
                                <td class="org-left">Montero et al. (2012)</td>
                            </tr>

                            <tr>
                                <td class="org-right">1+</td>
                                <td class="org-left">HR-/HER2-</td>
                                <td class="org-right">$189,450</td>
                                <td class="org-right">$142,088−236,813</td>
                                <td class="org-left">Montero et al. (2012)</td>
                            </tr>
                        </tbody>
                        <tbody>
                            <tr>
                                <td class="org-left" rowspan="2">Breast Cancer Death</td>
                                <td class="org-right">1</td>
                                <td class="org-left">All Subtypes</td>
                                <td class="org-right">$44,773</td>
                                <td class="org-right">$33,580−55,966</td>
                                <td class="org-left">Alvarado et al. (2013), Schousboe et al. (2011), Sorenson et al. (2012), Warren Suh et al. (2005)</td>
                            </tr>

                            <tr>
                                <td class="org-right">2+</td>
                                <td class="org-left">All Subtypes</td>
                                <td class="org-right">$0</td>
                                <td class="org-right">$0</td>
                                <td class="org-left">Alvarado et al. (2013)</td>
                            </tr>
                        </tbody>
                        <tbody>
                            <tr>
                                <td class="org-left" rowspan="2">Other Cause Death</td>
                                <td class="org-right">1</td>
                                <td class="org-left">All Subtypes</td>
                                <td class="org-right">$908</td>
                                <td class="org-right">$665−1,110</td>
                                <td class="org-left">Alvarado et al. (2013)</td>
                            </tr>

                            <tr>
                                <td class="org-right">2+</td>
                                <td class="org-left">All Subtypes</td>
                                <td class="org-right">$0</td>
                                <td class="org-right">$0</td>
                                <td class="org-left">Alvarado et al. (2013)</td>
                            </tr>
                        </tbody>
                    </table>
                </div>

                <!-- Modal footer -->
                <div class="modal-footer">
                    <button type="button" class="btn btn-secondary" data-dismiss="modal">Close</button>
                </div>

            </div>
        </div>
    </div>
    <!-- Include my script.js file -->
    <script type="text/javascript" src="script.js"></script>
</body>
</html>
